Improved synthesis and in vitro characterization of chitosan-thioethylamidine conjugate

被引:54
作者
Kafedjiiski, K
Hoffer, M
Werle, M
Bernop-Schnürch, A
机构
[1] Univ Innsbruck, Dept Pharmaceut Technol, Inst Pharm, A-6020 Innsbruck, Austria
[2] MucoBiomer GmbH, A-2100 Leobendorf, Austria
[3] ThioMatrix GmbH, A-6020 Innsbruck, Austria
基金
奥地利科学基金会;
关键词
thiolated chitosan; chitosan- thioethylamidine conjugate; isopropyl-S-acetylthioacetimidate hydrochloride; disintegration; oxidation; permeation enhancement;
D O I
10.1016/j.biomaterials.2005.05.075
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
The aim of this study was to establish improved reaction conditions for the synthesis of chitosan-thioethylamidine (Ch-TEA) conjugate and to evaluate the properties of the obtained Ch-TEA conjugate. The influence of different factors on the coupling reaction, such as concentration of chitosan solution, employment of reducing agent and deprotection of S-acetyl groups, was evaluated. The cohesive properties and stability of the obtained conjugate were evaluated by disintegration test and by oxidation experiments, respectively. The adhesive properties of Ch-TEA conjugate were evaluated in vitro on freshly excised porcine mucosa via tensile studies and the rotating cylinder method. The permeation-enhancing effect of Ch-TEA conjugate was evaluated in Ussing-type chambers by using rhodamine 123 as model compound. The resulting conjugate displayed 225 mu mol immobilized free thiol groups and 102 mu mol disulfide bonds per grain polymer. The degree of modification depends mostly on the chitosan concentration employed and the deprotection of S-acetyl groups with hydroxylamine. During oxidation studies the amount of thiol groups decreased by 61%. Disintegration studies of tablets comprising Ch-TEA demonstrated stability for 48 It. In tensile studies, the total work of adhesion of the conjugate was determined to be 5.1-fold increased ill comparison to unmodified chitosan. Results from the rotating cylinder method showed more than a 13-fold increase in the adhesion time of thiolated chitosan versus unmodified chitosan. The apparent permeability coefficient (P-app) of the system 0.5% (w/v) Ch-TEA conjugate with 5% (w/v) glutathione was calculated to be 5.35 x 10(-8) cm/s, while the P-app value of the system 0.5% (w/v) unmodified chitosan was 1.73 x 10(-8) cm/s. These features should render Ch-TEA useful as all excipient for various drug delivery systems. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:127 / 135
页数:9
相关论文
共 21 条
  • [1] Bemkop-Schnurch A, 1999, SCI PHARM, V67, P196
  • [2] Polymers with thiol groups:: A new generation of mucoadhesive polymers?
    Bernkop-Schnürch, A
    Schwarz, V
    Steininger, S
    [J]. PHARMACEUTICAL RESEARCH, 1999, 16 (06) : 876 - 881
  • [3] Permeation enhancing polymers in oral delivery of hydrophilic macromolecules:: thiomer/GSH systems
    Bernkop-Schnürch, A
    Kast, CE
    Guggi, D
    [J]. JOURNAL OF CONTROLLED RELEASE, 2003, 93 (02) : 95 - 103
  • [4] Thiomers:: potential excipients for non-invasive peptide delivery systems
    Bernkop-Schnürch, A
    Krauland, AH
    Leitner, VM
    Palmberger, T
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2004, 58 (02) : 253 - 263
  • [5] Thiolated chitosans:: development and in vitro evaluation of a mucoadhesive, permeation enhancing oral drug delivery system
    Bernkop-Schnürch, A
    Guggi, D
    Pinter, Y
    [J]. JOURNAL OF CONTROLLED RELEASE, 2004, 94 (01) : 177 - 186
  • [6] Thiolated polymers-thiomers:: synthesis and in vitro evaluation of chitosan-2-iminothiolane conjugates
    Bernkop-Schnürch, A
    Hornof, M
    Zoidl, T
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2003, 260 (02) : 229 - 237
  • [7] SELECTIVE REDUCTION OF DISULFIDES BY TRIS(2-CARBOXYETHYL)PHOSPHINE
    BURNS, JA
    BUTLER, JC
    MORAN, J
    WHITESIDES, GM
    [J]. JOURNAL OF ORGANIC CHEMISTRY, 1991, 56 (08) : 2648 - 2650
  • [8] The role of glutathione in the permeation enhancing effect of thiolated polymers
    Clausen, AE
    Kast, CE
    Bernkop-Schnürch, A
    [J]. PHARMACEUTICAL RESEARCH, 2002, 19 (05) : 602 - 608
  • [9] Clausen AE, 2000, J PHARM SCI-US, V89, P1253, DOI 10.1002/1520-6017(200010)89:10<1253::AID-JPS3>3.0.CO
  • [10] 2-8